Tech, Generics Cos. Spar With Tribes Over Allergan At PTAB
Allergan's plan to defeat inter partes reviews of patents on its eye drug Restasis by transferring them to a Native American tribe prompted over a dozen dueling amicus briefs Friday, with...To view the full article, register now.
Already a subscriber? Click here to view full article